The estrogenic and antiestrogenic activities of phytochemicals with the human estrogen receptor expressed in yeast

Steroids

Volumn 62, Issue 4, 1997, Pages 365-372

  Collins, Bridgette M ^a,b   McLachlan, John A ^a,b,c   Arnold, Steven F ^a,b,c  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TULANE UNIVERSITY MEDICAL CENTER   (United States)

^c TULANE UNIVERSITY   (United States)

Author keywords

antiestrogen; environmental estrogens; estrogen receptor; phytoestrogens; sterol; yeast

Indexed keywords

ALPHA ZEARALENOL; ANTIESTROGEN; BETA GALACTOSIDASE; BIOCHANIN A; CHRYSIN; COUMESTROL; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; FLAVONE DERIVATIVE; FULVESTRANT; GENISTEIN; ISOKAEMPFERIDE; NARIGENIN; PHLORETIN; POLYCHLORINATED BIPHENYL; STEROL; TAMOXIFEN; UNCLASSIFIED DRUG;

ARTICLE; CONFORMATIONAL TRANSITION; DIMERIZATION; ENZYME INHIBITION; GENE EXPRESSION; PHYTOCHEMISTRY; PROTEIN BINDING; RADIOASSAY; YEAST;

EID: 0030889085     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(96)00246-2     Document Type: Article

References (30)

1. Harris JR, Lippman ME, Veronesi V, Willett W (1992). Breast Cancer (2). New Engl J Med 327:390-398.
2. Aldercreutz H (1990). Western diet and Western diseases: Some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest 50:3-23.
3. Rose DP, Boyar AP, Wynder EL (1986). International comparison of mortality rates for cancer of the breast, ovary, prostate and colon, and per capita food consumption. Cancer 58:2263-2371.
4. Harborne JB (1973). Flavanoids. Phytochemistry 2:344-380.
5. Aldercreutz H (1995). Phytoestrogens: Epidemiology and a possible role in cancer protection. Estrogens in the Environment, III: Global health implications. Environ Health Perspec (suppl 7) 103:103-112.
6. Kellis JT, Vickery LE (1984). Inhibition of human estrogen synthetase (aromatase) by flavones. Science 225:1032-1034.
7. Makela S, Davis VL, Tally WC, Korkman J, Salo L, Vihko R, Santti R, Korach KS (1994). Dietary estrogens act through estrogen receptor-mediated processes and show no antiestrogencity in cultured breast cancer cells. Environ Health Perspec 102:572-578.
8. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S-I, Itoh N, Shibuya M, Fukami Y (1987). Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262:5592-5595.
9. Peterson G, Barnes S (1991). Genistein inhibition of the growth of human breast cancer cells: Independence from estrogen receptors and the multi-drug resistance gene. Biochem Biophy Res Comm 179:661-667.
10. Chae Y-H, Coffing SL, Cook VM, Ho DK, Cassady JM, Baird WM (1991). Effects of biochanin A on metabolism, DNA binding, and mutagenicity of benzo[a]pyrene in mammalian cell cultures. Carcinogenesis 12:2001-2006.
11. Peterson G, Barnes S (1993). Genistein and biochanin-A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor autophosphorylation. Prostate 22:335-345.
12. Hirano T, Oka K, Akiba M (1989). Antiproliferative effects of synthetic and naturally occurring flavonoids on tumor cells of the human breast carcinoma cell line, ZR-75-1. Res Comm Chem Path Pharm 64:69-78.
13. Mousavi Y, Aldercreutz H (1992). Enterolactone and estradiol inhibit each other's proliferative effect on MCF-7 breast cancer cells in culture. J Steroid Biochem Molec Biol 41:615-619.
14. Ruh MF, Zacharewski T, Connor K, Howell J, Chen I, Safe S (1995). Narigenin: A weakly estrogenic bioflavonoid that exhibits antiestrogenic activity. Biochem Pharm 50:1485-1493.
15. Miksicek RJ (1993). Commonly occurring plant flavanoids have estrogenic activity. Mol Pharm 44:37-43.
16. Arnold SF, Robinson MR, Notides AC, Guillette LJ Jr, McLachlan JA (1996). The availability of natural and synthetic estrogens in the yeast estrogen screen. Environ Health Perspect 104:584-588.
17. McDonnell DP, Pike JW, Drutz DJ, Butt TR, O'Malley BW (1989). Reconstitution of the vitamin D3 responsive osteocalcin transcription unit in yeast. Mol Cell Biol 39:3517-3523.
18. Pham TA, Hwung YP, Santiso-Mere D, McDonnell DP, O'Malley BW (1992). Ligand-dependent and -independent function of the transactivation regions of the human estrogen receptor in yeast. Mol Endocrinol 6:1043-1050.
19. Arnold SF, Klotz DM, Collins BM, Vonier PM, Guillette LJ Jr, McLachlan JA (1996). Synergistic activation of estrogen receptor with combinations of environmental chemicals. Science 272:1489-1492.
20. Wang H, Peters GA, Zeng X, Tang M, Ip W, Khan SA (1995). Yeast two-hybrid system demonstrates that estrogen receptor dimerization is ligand-dependent in vivo. J Biol Chem 270:23,322-23,329.
21. Miller JH (1972). In: Miller JH (ed), Experiments in Molecular Genetics. Cold Spring Harbor Laboratory, Cold Spring, NY. pp. 352-355.
22. Zysk JR, Johnson B, Ozenberger BA, Bingham B, Gorski J (1995). Selective uptake of estrogenic compounds by Saccharomyces cerevisiae: A mechanism for antiestrogen resistance in yeast expressing the mammalian estrogen receptor. Endocrinol 136:1323-1326.
23. Miksicek RJ (1994). Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptor. J Steroid Biochem Mol Biol 49:153-160.
24. Mayr U, Butsch A, Schneider S (1992). Validation of two in vitro test systems for estrogenic activities with zearalenone, phytoestrogens, and cereal extracts. Toxicology 74:135-149.
25. Martin PM, Horwitz KB, Ryan DS, McGuire WL (1978). Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinol 103:1860-1867.
26. Martin ME, Haourigui M, Pelissero C, Benassayag C, Nunez EA (1996). Interaction between phytoestrogens and human sex steroid binding protein. Life Sci 58:429-436.
27. Garreau B, Vallette G, Aldercreutz H, Wahala K, Makela T, Benassayag C, Nunez EA (1991). Phytoestrogens: New ligands for rat and human α-fetoprotein. Biochim Biophys Acta 1094:339-345.
28. Arnold SF, Collins BM, Robinson MR, Guillette LJ Jr, McLachlan JA. Differential interaction of natural and synthetic estrogens with extracellular binding proteins in a yeast estrogen screen. Steroids 61:642-646.
29. Hedden A, Muller V, Jensen EV (1995). A new interpretation of antiestrogen action. Ann NY Acad Sci 761:109-120.
30. Baniahmad C, Nawaz Z, Baniahmad A, Gleeson M, Tsai M, O'Malley B (1995). Enhancement of human estrogen receptor activity by SPT6: A potential coactivator. Mol Endocrinol 9:34-43.